Variable | n | Survival rate at 5 years (%) | Univariate P | Multivariate P relative risk (95% confidence interval) |
---|---|---|---|---|
Age (years) | Â | Â | 0.104 | Â |
<70 | 74 | 61.7 | Â | Â |
≥70 | 58 | 45.2 |  |  |
Sex | Â | Â | 0.165 | Â |
Male | 87 | 58.8 | Â | Â |
Female | 45 | 47.0 | Â | Â |
Lymphadenectomy | Â | Â | 0.647 | Â |
<D2 | 61 | 56.2 | Â | Â |
D2 | 71 | 54.8 | Â | Â |
Histological differentiation | Â | Â | 0.002 | 0.006 |
G1 or G2 | 58 | 70.7 | Â | 1 |
G3 or G4 | 74 | 41.2 | Â | 2.15 (1.23 to 3.85) |
Depth of tumor invasion | Â | Â | <0.001 | 0.040 |
pT2 or pT3 | 64 | 77.2 | Â | 1 |
pT4 | 68 | 35.6 | Â | 1.85 (1.03 to 3.47) |
Number of lymph node metastases | Â | Â | <0.001 | <0.001 |
pN0 or pN1 | 74 | 72.8 | Â | 1 |
pN2 or pN3 | 58 | 36.5 | Â | 2.71 (1.53 to 4.98) |
Lymphatic invasion | Â | Â | 0.016 | Â |
Negative | 45 | 70.7 | Â | Â |
Positive | 87 | 48.1 | Â | Â |
Venous invasion | Â | Â | 0.026 | Â |
Negative | 84 | 62.7 | Â | Â |
Positive | 48 | 39.4 | Â | Â |